Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Braz. J. Pharm. Sci. (Online) ; 59: e21770, 2023. tab, graf
Article in English | LILACS | ID: biblio-1439547

ABSTRACT

Abstract The locust bean gum (LBG) is a polysaccharide with thickening, stabilizing and gelling properties and it has been used in the preparation of pharmaceutical formulations. Hydrogels (HGs) are obtained from natural or synthetic materials that present interesting properties for skin application. This study aimed to develop HGs from LBG using indole-3-carbinol (I3C) as an asset model for cutaneous application. HGs were prepared by dispersing LBG (2%, 3% and 4% w/v) directly in cold water. The formulations showed content close to 0.5 mg/g (HPLC) and pH ranging from 7.25 to 7.41 (potentiometry). The spreadability factor (parallel plate method) was inversely proportional to LBG concentration. The rheological evaluation (rotational viscometer) demonstrated a non-Newtonian pseudoplastic flow behavior (Ostwald De Weale model), which is interesting for cutaneous application. The HET-CAM evaluation showed the non-irritating characteristic of the formulations. The bioadhesive potential demonstrated bioadhesion in a concentration-dependent manner. Permeation in human skin using Franz cells showed that the highest LBG concentration improved the skin distribution profile with greater I3C amounts in the viable skin layers. The present study demonstrated the feasibility of preparing HGs with LBG and the formulation with the highest polymer concentration was the most promising to transport active ingredients through the skin.


Subject(s)
Polysaccharides/analysis , Rubber/analysis , Hydrogels/analysis , Potentiometry/instrumentation , Pharmaceutical Preparations/administration & dosage , Chromatography, High Pressure Liquid/methods , Skin Cream/classification
2.
Med Pr ; 65(2): 297-305, 2014.
Article in Polish | MEDLINE | ID: mdl-25090859

ABSTRACT

Contact dermatitis is a common skin disease in the workplace and at home. Due to the high incidence of skin diseases the European Union countries have taken the activity to reduce or minimize this problem by the promotion of skin protection program, based on the application of skin protection measures - barrier creams and moisturizers. Definitions, reasons, mechanism of action and duration, application of methods, as well as the efficacy of using skin protection products in different workplaces are extensively reviewed in this article. Correctly matched barrier preparations protect against harmful factors and irritants, facilitating at the same time hand washing at the end of the working day, and together with the use of suitable non-irritating detergents and skin care products are important elements contributing to the prevention of occupational skin diseases. They shouldn't be used as a primary protection against high-risk substances. Numerous creams declared as the skin protection measures are on the market, so a careful selection of appropriate effective skin protecting barrier cream for the specific situations/environments is recommended.


Subject(s)
Dermatitis, Contact/prevention & control , Dermatitis, Occupational/prevention & control , Hand Dermatoses/prevention & control , Skin Cream/administration & dosage , Administration, Topical , Guidelines as Topic , Humans , Skin Cream/classification , Skin Cream/standards , Workplace/classification
3.
Cutis ; 91(6): 308-14, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23837155

ABSTRACT

Xerosis is a highly prevalent condition that can be caused by environmental factors, age, or various diseases. Although the causes, symptoms, and severity of dry skin vary widely, moisturizers form the mainstay of treatment in simple cases and can be used as adjunctive therapy in more serious clinical cases. The market now contains a plethora of moisturizing formulations from which consumers can choose, but dermatologists need to distinguish among marketing claims, anecdotal evidence, and proven clinical effects when recommending moisturizers to their patients. Many lesser-quality moisturizers were never designed to mitigate dry skin or more serious skin conditions in a therapeutically relevant manner and are unlikely to provide clinically adequate moisturizing therapy. This article aims to clarify some common prevailing myths and misconceptions about moisturizers in the dermatology community. Recent advances in research have revealed that natural moisturizing factor (NMF), ceramides, and aquaporins (AQPs) are key factors in skin hydration. The impact of these advances on the ingredients that are being used in moisturizers is discussed, along with the importance of dermatologists choosing clinically proven products released by laboratories with demonstrated track records in research.


Subject(s)
Skin Cream/classification , Skin Cream/therapeutic use , Skin Diseases/drug therapy , Aquaporins , Emollients , Humans , Hygroscopic Agents , Lipids , Ointments
SELECTION OF CITATIONS
SEARCH DETAIL
...